Clinical Trials Logo

Clinical Trial Summary

The goals of this protocol is to diagnose, care for, and understand the clinical histories and outcomes of people with leukodystrophies.


Clinical Trial Description

Inherited leukodystrophies affect close to 1 in 7500 children with mortality greater than 30%. Affected patients face additional serious medical complications including epilepsy, developmental regression, and intellectual disabilities. Diagnosis is difficult and requires the assistance of a specialist. Finally, identifying treatments and improving outcomes is complex. The Western Leukodystrophy Project, which is part of the University of Utah and of Primary Children's Hospital, and which is a certified Leukodystrophy Care Network Center, provides a specialized resource for patients with leukodystrophies. This clinical study assists with diagnosis of leukodystrophies; suggesting treatment options and implementing care guidelines, and improving outcomes for all patients by understanding the clinical histories and outcomes of affected patients.. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03639285
Study type Observational [Patient Registry]
Source University of Utah
Contact Josh Bonkowsky, MD, PhD
Phone 8012133599
Email joshua.bonkowsky@hsc.utah.edu
Status Recruiting
Phase
Start date January 19, 2007
Completion date December 31, 2050

See also
  Status Clinical Trial Phase
Recruiting NCT01793168 - Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Active, not recruiting NCT02699190 - LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
Recruiting NCT03333200 - Longitudinal Study of Neurodegenerative Disorders
Recruiting NCT05443906 - Home Exercise for Individuals With Neurodegenerative Disease N/A
Recruiting NCT03047369 - The Myelin Disorders Biorepository Project
Completed NCT00889174 - The Nosology and Etiology of Leukodystrophies of Unknown Causes